Literature DB >> 21205832

Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening.

Robert A Smith1, Vilma Cokkinides, Durado Brooks, Debbie Saslow, Mona Shah, Otis W Brawley.   

Abstract

Each year the American Cancer Society (ACS) publishes a summary of its recommendations for early cancer detection, a report on data and trends in cancer screening rates, and select issues related to cancer screening. This article summarizes the current ACS guidelines, describes the anticipated impact of new health care reform legislation on cancer screening, and discusses recent public debates over the comparative effectiveness of different colorectal cancer screening tests. The latest data on the utilization of cancer screening from the National Health Interview Survey is described, as well as several recent reports on the role of health care professionals in adult utilization of cancer screening.

Entities:  

Mesh：

Year:  2011        PMID： 21205832     DOI： 10.3322/caac.20096

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  94 in total

1.  Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.

Authors:  Tara O Henderson; Kevin C Oeffinger; John Whitton; Wendy Leisenring; Joseph Neglia; Anna Meadows; Catherine Crotty; David T Rubin; Lisa Diller; Peter Inskip; Susan A Smith; Marilyn Stovall; Louis S Constine; Sue Hammond; Greg T Armstrong; Leslie L Robison; Paul C Nathan
Journal:  Ann Intern Med       Date:  2012-06-05       Impact factor: 25.391

2.  Gender differences in cancer screening beliefs, behaviors, and willingness to participate: implications for health promotion.

Authors:  Jenna L Davis; Kyrel L Buchanan; Ralph V Katz; B Lee Green
Journal:  Am J Mens Health       Date:  2011-11-08

3.  Distinguishing factors for asymptomatic colonoscopy screening.

Authors:  Corey H Basch; Charles E Basch; Randi L Wolf; Patricia Zybert
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

4.  Opportunities for the primary prevention of colorectal cancer in the United States.

Authors:  Corinne E Joshu; Giovanni Parmigiani; Graham A Colditz; Elizabeth A Platz
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-28

5.  IMP3 expression in biopsy specimens of colorectal cancer predicts lymph node metastasis and TNM stage.

Authors:  Qingzhu Wei; Xiaoping Huang; Bo Fu; Jianghuan Liu; Ling Zhong; Qiao Yang; Tong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?

Authors:  Morten Valberg; Tom Grotmol; Steinar Tretli; Marit B Veierød; Tron A Moger; Susan S Devesa; Odd O Aalen
Journal:  Eur J Epidemiol       Date:  2016-07-18       Impact factor: 8.082

7.  Computer-aided diagnosis of breast DCE-MRI images using bilateral asymmetry of contrast enhancement between two breasts.

Authors:  Qian Yang; Lihua Li; Juan Zhang; Guoliang Shao; Chengjie Zhang; Bin Zheng
Journal:  J Digit Imaging       Date:  2014-02       Impact factor: 4.056

8.  A novel functional infrared imaging system coupled with multiparametric computerised analysis for risk assessment of breast cancer.

Authors:  Tamar Sella; Miri Sklair-Levy; Maya Cohen; Mona Rozin; Myra Shapiro-Feinberg; Tanir M Allweis; Eugene Libson; David Izhaky
Journal:  Eur Radiol       Date:  2012-12-06       Impact factor: 5.315

9.  Five-year downstream outcomes following prostate-specific antigen screening in older men.

Authors:  Louise C Walter; Kathy Z Fung; Katharine A Kirby; Ying Shi; Roxanne Espaldon; Sarah O'Brien; Stephen J Freedland; Adam A Powell; Richard M Hoffman
Journal:  JAMA Intern Med       Date:  2013-05-27       Impact factor: 21.873

Review 10.  Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries.

Authors:  Meteb Al-Foheidi; Mubarak M Al-Mansour; Ezzeldin M Ibrahim
Journal:  Med Oncol       Date:  2013-02-19       Impact factor: 3.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.